+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Prions"

From
From
Proteomics - Technologies, Markets and Companies - Product Thumbnail Image

Proteomics - Technologies, Markets and Companies

  • Report
  • November 2021
  • 656 Pages
  • Global
From
Neuroprotection - Methods, Drugs, Markets and Companies - Product Thumbnail Image

Neuroprotection - Methods, Drugs, Markets and Companies

  • Report
  • November 2021
  • 844 Pages
  • Global
From
  • 10 Results (Page 1 of 1)
Loading Indicator

Prions are proteins that can cause a range of neurological diseases, including Creutzfeldt-Jakob disease (CJD) and mad cow disease. Prions are responsible for a number of neurological disorders, including dementia, seizures, and motor neuron diseases. As such, they are a major focus of research and development in the field of central nervous system drugs. The prion market is driven by the need to develop treatments for these diseases, as well as to develop diagnostic tests to detect them. Prion-based drugs are being developed to treat a range of neurological disorders, including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS). Additionally, research is being conducted to develop vaccines to prevent prion-related diseases. The prion market is highly competitive, with a number of companies involved in the development of prion-based drugs and diagnostics. These include Biogen, AbbVie, Merck, Pfizer, and Novartis. Additionally, a number of smaller companies are involved in the development of prion-based treatments and diagnostics. Show Less Read more